We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Almost two years after buying back majority control of CannPal Animal Therapeutics from the recently...
Read ArticleJust two years after medicinal cannabis company AusCann (ASX: AC8) acquired CannPal Animal Therapeut...
Read ArticleThe Australian medicinal cannabis market has seen strong growth in 2021, with revenue from product s...
Read ArticleAustralian medicinal cannabis company AusCann (ASX: AC8) today announced it is preparing a trial of...
Read ArticleCannabis stocks have welcomed the change in ownership of Pershing Australia from Bank of New York Me...
Read ArticleThe ASX saw the best IPO debut of the year to date in manganese explorer Firebird Metals (ASX:FRB),...
Read ArticleCannPal Animal Therapeutics (ASX: CP1) shareholders voted overwhelmingly in favour of allowing canna...
Read ArticleSummary With COVID-19 giving the opportunity to develop products, enhance services and conduct R...
Read ArticleAustralia has one of the highest rates of household pet ownership in the world. The RSPCA estimates...
Read ArticleLayton Mills' company CannPal Animal Therapeutics (ASX: CP1) may be the target in a scrip-based acqu...
Read ArticleIt’s been another positive day on the ASX in the wake of Democrats gaining control of the US Senate...
Read ArticleSummary AusCann Group to change its CEO after completing the acquisition of the animal health c...
Read ArticleThe AusCann Group Holdings Ltd (ASX: AC8) share price is on the move on Friday after the release of...
Read ArticleThe CannPal Animal Therapeutics Ltd (ASX: CP1) share price is shooting higher today, rising 20% to...
Read ArticleThe Auscann Group Holdings Ltd (ASX: AC8) and Cannpal Animal Therapeutics Ltd (ASX: CP1) share pric...
Read ArticleAustralian Pharmaceutical company AusCann Group Holdings Ltd (ASX:AC8) has entered a scheme implemen...
Read ArticleSpecial Report: CannPal Animal Therapeutics (ASX:CP1) has entered into a scheme implementation deed...
Read ArticleTwo major ASX-listed medicinal cannabis companies could soon be under one roof after the board of Ca...
Read ArticleSpecial Report: Animal Health company CannPal Animal Therapeutics is moving forward with bringing it...
Read ArticleASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re...
Read ArticleStockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment...
Read ArticleA quick wrap of the ASX’s key winners and losers on Thursday, August 6. Data is taken after the mark...
Read ArticleNearly two years of pain for Factor Therapeutics (ASX:FTT) shareholders could be over soon with the...
Read ArticleCannPal Animal Therapeutics (ASX: CP1) is a step closer to commercialisation after its oral hemp-bas...
Read ArticlePet pharmaceuticals company CannPal (ASX: CP1) is in advanced discussions with commercialisation par...
Read ArticleSpecial Report: Animal health company CannPal has released data from a study into its hemp-derived c...
Read ArticleA quick wrap of the ASX’s key winners and losers on Tuesday, July 7. Data is taken after the market...
Read ArticleNorth American pot stocks are roaring back from lows in March but the same cannot be said for their...
Read ArticleSpecial Report: Cannabis products for pets is big business but just two ASX-listed companies are pay...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAfter a morning scare, the ASX managed to pare back its losses to close slightly green. While to...
Read ArticleCannPal Animal Therapeutics (CP1) has been granted global rights to commercialise its MicroMAX micr...
Read ArticleCommercialisation is on the cards for pet pharmaceuticals company CannPal (ASX: CP1) after the compa...
Read ArticleFollowing an 18 month review, CannPal (ASX: CP1) has secured exclusive rights to commercialise the C...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleMarijuana is the hottest herb on the planet right now, but while investing in medical cannabis stock...
Read ArticlePot stock THC Global (ASX:THC) is in business at Southport, the largest medicinal cannabis productio...
Read ArticleWho needs human companionship when we have pets? They’re loyal, always happy to see you and won’t di...
Read ArticleCannabis Shares Valuing a cannabis company is becoming an increasingly difficult task. Lately, the c...
Read ArticleAll eyes were on the nation’s capital yesterday, as the ACT became the first Australian state or ter...
Read ArticleIt is now accepted that cannabis is not just for those wanting to get high; it has potential to addr...
Read ArticleWth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
